Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 C pseudogene 2 (UBE2CP2)

Target
UBE2CP2
Molecular classification
Other (Pseudogene)
01

Overview

Ubiquitin conjugating enzyme E2 C pseudogene 2 (UBE2CP2) is classified as a pseudogene and does not encode a functional protein product. It is related by sequence homology to the UBE2C gene, which itself encodes an active E2 ubiquitin-conjugating enzyme involved in ubiquitin-mediated protein degradation. However, UBE2CP2 lacks documented expression of a functioning protein and is not known to have a direct biological or disease role, nor is it a therapeutic target. Gene databases and scientific resources do not report any clinically-relevant activity, ligand binding, or disease association for this pseudogene. Therefore, based on public genomic databases and current knowledge, UBE2CP2 is not a valid or actionable drug target, and any references suggesting otherwise are likely due to misclassification or confusion with the functional gene UBE2C.

Other names
UBE2CP2ubiquitin-conjugating enzyme E2C pseudogene 2

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 C pseudogene 2 (UBE2CP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 C pseudogene 2 (UBE2CP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call